Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label Study.
J Invest Dermatol
; 142(8): 2109-2116.e4, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35131254
Full text:
1
Database:
MEDLINE
Main subject:
Janus Kinase Inhibitors
/
Lichen Planus
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Invest Dermatol
Year:
2022
Type:
Article
Affiliation country:
United States